The STEP-1 trial reported approximately 15% average body weight reduction with semaglutide 2.4mg over 68 weeks
JAMA 292 (4), 490495
This background allows your care to stay coordinated, personal, and aligned with your broader womens health goals
A 2026 Journal of the American Academy of Dermatology cohort study specifically examined new-onset hair loss with semaglutide and tirzepatide, showing that this is now an active area of dermatology research
504,505,506 GLP-1 enhances the insulin signaling pathway in the liver by activating the GLP-1R, especially through the phosphorylation of insulin receptor substrates and the activation of the PI3K/Akt signaling pathway, thereby increasing hepatic insulin sensitivity, facilitating glucose uptake and utilization, and reducing hepatic gluconeogenesis
doi: 10.1002/oby.21577 243 NunnEJaiswalNGavinMUeharaKStefkovichMDrareniKet al